Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | D2C7-IT |
Trade Name | |
Synonyms | D2C7-(scdsFv)-PE38KDEL |
Drug Descriptions |
D2C7-IT is an immunotoxin engineered by linking a fragment of the D2C7 monoclonal antibody recognizing wild-type EGFR and EGFRvIII with Pseudomonas Exotoxin A (PE38KDEL), which targets tumor cells expressing wild-type EGFR and/or EGFRvIII, potentially resulting in decreased tumor growth (PMID: 28286803, PMID: 31142380). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C119739 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
2141 V-11 + D2C7-IT | 2141 V-11 D2C7-IT | 0 | 3 |
Atezolizumab + D2C7-IT | Atezolizumab D2C7-IT | 0 | 1 |
D2C7-IT | D2C7-IT | 0 | 1 |